"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV

Left, Right & Centre: "This (approval of Covaxin) is excellent news. WHO follows stringent guidelines - a lot of data points need to be submitted. We should not overreact to the delay in its approval," says Biocon's Executive Chairperson Kiran Mazumdar Shaw.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Koo: https://www.kooapp.com/profile/ndtv
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#LeftRight&Centre